Symposier - Stem Cell Therapy in Cardiac Disease
Links shared publicly online about this topic.
- 1,565total visits
Symposier - Stem Cell Therapy in Cardiac Disease
View full resource at symposier.com
Tags: Heart, Disease and Condition, Stem Cell
Most Recently Shared on November 30, 2009 at 6:12 am By:
Using stem cell therapy to treat cardiac disease -->http://bit.ly/4VBpyn // Shared at Symposier
Cytori Reports Sustained Benefits At 18 Months In Cardiac Cell Therapy Heart Attack Trial
medicalnewstoday.com — “Cytori Therapeutics (NASDAQ: CYTX) is reporting 18 month outcomes from its APOLLO trial for Acute Myocardial Infarction (AMI). The results from the 14 patient, randomized, placebo-controlled, doub” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2011 at 6:20 pm By:
Cytori Reports Sustained Benefits At 18 Months In Cardiac Cell Therapy Heart Attack Trial: Cytori Therapeutics (... http://bit.ly/mn6DpA
Cytori Reports Sustained Benefits At 18 Months In Cardiac Cell Therapy Heart Attack Trial
medicalnewstoday.com — “Cytori Therapeutics (NASDAQ: CYTX) is reporting 18 month outcomes from its APOLLO trial for Acute Myocardial Infarction (AMI). The results from the 14 patient, randomized, placebo-controlled, doub” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2011 at 5:15 pm By:
MedicalNewsToday: Cytori Reports Sustained Benefits At 18 Months In Cardiac Cell Therapy: http://bit.ly/iPiKqz Full http://bit.ly/lP4Dug
Symposier - ESMO: First-Line Erlotinib Improves NSCLC Outcomes
symposier.com — “Uploaded and shared in Youtube by: MedPageToday " MILAN -- Non-small cell lung cancer patients (NSCLC) with advanced disease achieved a substantial and highly-significant survival advantage when they received initial therapy with erlotinib (Tarceva) rather than a standard chemotherapy regimen, researchers said here.” View full resource at symposier.com
Most Recently Shared on October 21, 2010 at 8:02 pm By:
First-Line Erlotinib Improves Non-small cell lung cancer patients Outcomes. http://bit.ly/cKAa3p
Cardiovascular Diseases on #MDlinx
mdlinx.com — “Cardiovascular Diseases on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 19, 2010 at 12:50 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardiac Cell Therapies: The Next Generation: Cardiovascular Drug Reviews http://bit.ly/aLEuHz #cardiology
Symposier - Mayo Clinic Reports its First Lung Transplantation by Donation After Cardiac Death
symposier.com — “Uploaded and Shared in Youtube by:mayoclinic Lung transplantation is a well-known therapy for patients with end-stage lung disease, but, as with other patients waiting for organs for transplantation, there are more recipients waiting than donors available. A potential solution for patients with end-stage lung disease is donation after cardiac death (DCD). Mayo Clinic reports its " and Minnesotas" first lung transplantation from DCD in the February issue of Mayo Clinic Proceedings. While brain de” View full resource at symposier.com
Most Recently Shared on March 5, 2010 at 7:38 pm By:
Mayo Clinic Reports its First Lung Transplantation by Donation After Cardiac Death. http://bit.ly/d5PWUo
Biological Therapies for Cardiac Arrhythmias | Cardiology
touchcardiology.com — “Title: Biological Therapies for Cardiac Arrhythmiasshort title: Biological Therapies for Cardiac ArrhythmiasShort summary: Over the past 50 years cell and then gene therapy have been attempted for a variety of diseases, with” View full resource at touchcardiology.com
Most Recently Shared on October 28, 2009 at 8:09 am By:
Touch Cardiology Cardiology and Health News
Biological Therapies for Cardiac Arrhythmias http://ow.ly/vCwO
Advertisement
